HEALTH OF WOMAN. 2016.2(108):150–154 
 

Optimisation of hormonal contraception at patients with chronic pyelonephritis 
 

Ledin D. S.

National Medical Academy of Postgraduate Education P. L. Shupyk, Kiev 
 

Research objective: studying of possibility use of hormonal contraception at patients with chronic pyelonephritis.

Material and methods: 1 group of 100 women of reproductive age with chronic pyelonephritis which used various methods of contraceptions: Subgroup 1.1 – 50 women with chronic pyelonephritis which used intrauterine contraception; Subgroup 1.2 – 50 women with chronic pyelonephritis, which use a combination of hormonal contraception and herbal medicine. Control group 50 women of reproductive age without экстрагенитальной have made pathologies which used mechanical means of contraception. Clinical, functional, laboratory and statistical methods have been included in a complex of the spent researches.

Results. Effective of hormonal contraception at women with chronic pyelonephritis makes 100,0%, thus frequency the collateral effects increases from 6,0% in 3 months to 10,0% in 1 year (between menstrual hemorragia – 4.0%; mastalgia – 4.0%; a pathological increase of weight of body (4–5 kg) – 2.0%). Level of the compelled refusal makes 4.0%. The positive moments are decrease within year of frequency dysmenorrea (from 10.0% to 2.0%) and premenstrual syndrome (from 8.0% to 2.0%). Use intrauterine contraceptions at women with chronic pyelonephritis has efficiency of 96.0%. Frequency of the compelled removal of a contraceptive makes 22.0% (full or partial expulshione – 10.0%; salpingooforites – 4.0%; hyperpolymenorrea – 4.0% and painful syndrome – 4.0%). The total indicator collateral effects increases from 12.0% in 3 months of 28.0% – in 1 year (between menstrual hemorragia – 12.0%; infringements microbiocenose of sexual ways – 10.0% and 6.0% – dyspareunia).

The conclusion. For optimisation of contraception at women with a chronic pyelonephritis probably use of a combination hormonal and phytopreparations.

Key words: hormonal contraception, a chronic pyelonephritis, optimisation.

REFERENCES

1. Ventskivskyy BM, Tovstanovska BO. 2012. Contraception: compare and prospects. New Medicine 4: 21-27.

2. Vertyschenko AB, Prysyadko MM. 2012. Methods of contraception and their role in the health of modern woman. Pediatrics, Obstetrics and Gynecology 4: 31-40.

3. Vovk KB, Peterburzhska VF. 2011. Hormone therapy of various disorders of menstrual function in women reprodactive period: 16.

4. Zhuk SI, Zahurdaeva LD. 2014. Hormonal contraception and ways to optimize its use. Women Health 7: 184-187.

5. Bayson LW, Hughbert OJ. 2013. Intrauterine contraception as a solution for modern woman. JAMA. 283:1430-6.

6. Birkhдuser M. 2014. Progestagen use in oral contraception – basic knowledge. Ther Umsch. 66(2):71–87.

7. Cameron S. 2012. Contraception and gynaecological care. Best Pract Res Clin Obstet Gynaecol. 23(2):211–20. http://dx.doi.org/10.1016/j.bpobgyn.2008.11.003; PMid:19147411